Yan Du
7 Papers
1 Citations
Yan Du is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 6 publications.
Chat about Author
Papers
Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy
Hao Feng,Lin Qiu,Zixiao Shi,Yao Sheng,Pei-Ge Zhao,Di Zhou,Fei Li,Hailin Yu,Yanan You,Hui Wang,Ming Li,Shurong Zhu,Yan Du,Jun Cui,Jingwei Sun,Yarong Liu,Hua Jiang,Xin-ru Wu +17 more
TL;DR: Modulation of PI3K-AKT signaling represents a promising strategy to enhance TIL stemness and cytotoxicity and improve the clinical outcome of current TIL-based therapy to treat solid tumors.
6
Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol
Libei Du,Raymond H.W. Li,Kristina Gemzell-Danielsson,Yan Du,Li Zhang,Weihua Diao,Pak Chung Ho +6 more
TL;DR: This randomised controlled trial is designed to test the hypothesis that for first-trimester missed miscarriage, letrozole pretreatment is non-inferior to mifepristone pretreatment followed by misoprostol in terms of complete abortion rate.
A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial
Xin Wu,Hao Feng,Shujun Gao,Hua Feng,Wenjing Diao,Hongwei Zhang,Ming Du,Weihua Lou,Xipeng Wang,Tao Zhu,Yuyang Zhang,Weiguo Hu,Xiao-hong Xue,Zhi-Gang Zhu,Libing Xiang,Jiarui Li,Xuhong Fang,Yongrui Bai,Y. Hou,Weili Yan,Lin Qiu,Hailin Yu,Shurong Zhu,Yan Du,Hua Jiang +24 more
TL;DR: In this paper , the authors conducted a randomized controlled trial to confirm whether there is a difference between laparoscopic radical hysterectomy (RH) and abdominal RH in cervical cancer (stage IA1 with LVSI, IA2) patients.
1
Development of cervical cancer patient reported clinical outcome assessment scale (CC-PRO137): A dedicated tool for multidimensional evaluation of treatment outcomes.
Xin Wu,Lin Qiu,Shurong Zhu,Hao Feng,Hui Wang,Yingchun Hou,Tao Zhang,Hailin Yu,Junda Zhao,Ming Li,Yanan You,Yuan Ruan,Yan Du,Hua Jiang +13 more
TL;DR: Wang et al. as mentioned in this paper developed a scale, Cervical Cancer Patient Reported Clinical Outcome Assessment Scale (CC-PRO137), aimed to construct a functional patient self-report system scale to quantify the quality of life of cervical cancer patients from multiple dimensions.
A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial
Xin Wu,Lin Qiu,Weihua Lou,Xipeng Wang,Tao Zhou,Yuyang Zhang,Weiguo Hu,Xiao-hong Xue,Zhiliang Zhu,Libing Xiang,Jiarui Li,Xuhong Fang,Shujun Gao,Hua Feng,Wenjing Diao,Hongwei Zhang,Ming Du,Yongrui Bai,Yanli Hou,Weili Yan,Hao Feng,Hailin Yu,Shurong Zhu,Yan Du,Hua Jiang +24 more
TL;DR: In this paper , the authors conducted a randomized controlled trial to confirm whether laparoscopic radical hysterectomy (RH) was associated with worse survival than abdominal RH among patients with early stage cervical cancer.